This article discusses the TTAB's decision in Bayer regarding how and when a foreign trademark can be used.
Related Professionals
-
Partner and National Co-Chair, Trademark/Copyright/Privacy Group+1.212.940.8554
-
Related Practices
Related Industries
Related Offices
Recent Articles
-
UK Securitisation Framework: Regulators Consult on Further Streamlining
February 19, 2026
-
Best Practices for Governance Documents in Ambulatory Surgery Centers
January 30, 2026
-
From the Locked Medicine Cabinet to Locker Rooms: The Sports Playbook for Medication Compliance; Assessing the Risks and Realities
January 29, 2026